The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Until today this year the stock’s price performance recorded an increase of 28.31%. However, over the last six months, the performance has been stronger by -70.92%. The price of SKYE decreased -33.90% over the last 30 days. And in the last five days, it has fallen by -39.83%.
In terms of market performance, Skye Bioscience Inc had a somewhat regular. The highest value for the stock in the past year was $19.41 on 03/04/24, while the lowest value was $1.44 on 12/01/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of SKYE Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Skye Bioscience Inc’s current trading price is -82.02% away from its 52-week high, while its distance from the 52-week low is 142.36%. The stock’s price range over this timeframe has been between $1.44 and $19.41. The shares of the Healthcare sector company recorded a trading volume of approximately 1.88 million for the day, which was comparatively higher than the average daily volume of 0.31 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Skye Bioscience Inc (SKYE) has experienced a quarterly decline of -58.45% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 105.89M and boasts a workforce of 11 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 7.93, with a change in price of -9.44. Similarly, Skye Bioscience Inc recorded 268,592 in trading volume during the last 100 days, posting a change of -73.01%.
SKYE’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for SKYE stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.00.
SKYE Stock Stochastic Average
The raw stochastic average for Skye Bioscience Inc over the last 50 days is presently at 11.94%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 11.94%. Further, the company’s Stochastic %K and %D values for the last 20 days were 13.57% and 16.03%, respectively.
